Publicacións (16) Publicacións de Oscar Prada Delgado

2024

  1. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

2022

  1. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

  2. Real world comparison of spironolactone and eplerenone in patients with heart failure

    European Journal of Internal Medicine, Vol. 97, pp. 86-94

2021

  1. Differences in the clinical profile and management of atrial fibrillation according to gender. Results of the registro gallego intercéntrico de fibrilación auricular (regueifa) trial

    Journal of Clinical Medicine, Vol. 10, Núm. 17

  2. Diseño y características basales del estudio REGUEIFA (Registro Gallego Intercéntrico de Fibrilación Auricular)

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 197-207

  3. Rationale, design and basal characteristics of REGUEIFA study (Multicenter Registry of Atrial Fibrillation in Galicia)

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 197-207

2015

  1. Valor pronóstico de la disfunción ventricular izquierda inducida por el ejercicio en pacientes hipertensos sin enfermedad arterial coronaria

    Revista Espanola de Cardiologia, Vol. 68, Núm. 2, pp. 107-114

2014

  1. Long-term prognostic value of mitral regurgitation in patients with st-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

    American Journal of Cardiology, Vol. 113, Núm. 6, pp. 907-912

2013

  1. Effect of atrioventricular optimization on circulating N-terminal pro brain natriuretic peptide following cardiac resynchronization therapy

    European Journal of Heart Failure, Vol. 15, Núm. 5, pp. 534-542

  2. Long-term prognostic benefit of field triage and direct transfer of patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

    American Journal of Cardiology, Vol. 111, Núm. 12, pp. 1721-1726

2012

  1. Percutaneous coronary interventions and bypass surgery in patients with cardiac allograft vasculopathy: A single-center experience

    Transplantation Proceedings

  2. Prevalence and prognostic value of cardiac allograft vasculopathy 1 year after heart transplantation according to the ISHLT recommended nomenclature

    Journal of Heart and Lung Transplantation

  3. Rate-adaptive AV delay and exercise performance following cardiac resynchronization therapy

    Heart Rhythm, Vol. 9, Núm. 11

  4. Renal insufficiency and vascular complications after primary angioplasty via femoral route. Impact of vascular closure devices use

    Revista Espanola de Cardiologia, Vol. 65, Núm. 3, pp. 258-264

2011

  1. Ortner's syndrome

    New England Journal of Medicine, Vol. 365, Núm. 10, pp. 939

  2. Safety and efficacy of femoral vascular closure devices in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction

    American Heart Journal, Vol. 161, Núm. 6, pp. 1207-1213